Oragenics
OGEN
10 hedge funds and large institutions have $41.6M invested in Oragenics in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and closing their positions.
43% more funds holding
Funds holding: 7 → 10 (+3)
26% more capital invested
Capital invested by funds: $33M → $41.6M (+$8.62M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
+$5.64M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.45M |
| 3 |
MP
MSD Partners
New York
|
+$1.15M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$313K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$104K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TS
1
Third Security
Radford,
Virginia
| $27.6M | +$5.64M | +108 | +25% |
|
|
2
Fidelity Investments
Boston,
Massachusetts
| $8.08M | +$3.45M | +66 | +71% |
|
|
MP
3
MSD Partners
New York
| $4.85M | +$1.15M | +22 | +30% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $618K | +$313K | +6 | +100% |
|
|
5
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $128K | +$104K | +2 | +200% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $106K | – | – | – |
|
|
EEG
7
E.E. Geduld
| $70K | +$52.2K | +1 | New |
|
|
VKH
8
Virtu KCG Holdings
New York
| $49K | +$52.2K | +1 | New |
|
|
SIM
9
Spark Investment Management
New York
| $41K | +$52.2K | +1 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $33K | – | – | – |
|
|
U
11
UBS
Zurich,
Switzerland
| $4K | – | – | – |
|
12
California Public Employees Retirement System
Sacramento,
California
| $3K | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
OGEN Hedge Fund Activity: Q4 2013 in Review
10 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2013, worth a combined $41.6M — up 26% from $33M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OGEN positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Third Security, adding an estimated $5.64M.
- 10 institutional investors held Oragenics (OGEN) as of Q4 2013, up from 7 in Q3 2013.
- Funds reported $41.6M of Oragenics stock for Q4 2013, up 26% quarter-over-quarter.
- 3 funds opened new Oragenics positions in Q4 2013 and 0 closed out, a net change of +3 holders.
- The largest Oragenics buyer in Q4 2013 was Third Security, an estimated $5.64M added.
Based on aggregated 13F filings for Q4 2013.